Skip to main content

Table 2 Anthropometrical and biochemical characteristics of study subjects: with and without high glycaemia

From: Inverse relation between FASN expression in human adipose tissue and the insulin resistance level

Patients

Control

High Glycaemia

P

BMI

26.18 ± 4.80

29.51 ± 4.29

0.03

SBP

126.70 ± 18.79

137.75 ± 16.38

0.06

DBP

76.35 ± 10.13

77.50 ± 11.68

0.72

W-H

0.89 ± 0.08

0.91 ± 0.07

0.26

Insulin

12.28 ± 6.29

14.93 ± 8.02

0.20

Glucose

83.78 ± 9.40

136.36 ± 52.61

0.01

HbA1c

5.59 ± 0.38

6.70 ± 0.66

0.00

HOMA-IR

2.56 ± 1.38

5.02 ± 2.50

0.01

Cholesterol

201.43 ± 34.37

194.45 ± 52.35

0.68

TG

105.78 ± 49.68

195.64 ± 113.98

0.03

LDL-c

125.36 ± 26.61

110.91 ± 35.28

0.11

HDL-c

53.81 ± 13.35

49.27 ± 12.10

0.29

CRP

5.75 ± 13.89

3.23 ± 2.58

0.55

Adiponectin

18.94 ± 11.68

14.08 ± 5.68

0.16

Leptin

17.32 ± 17.77

26.83 ± 19.96

0.10

FASN

0.27 ± 0.17

0.08 ± 0.03

0.00

PPARγ1

0.07 ± 0.20

0.03 ± 0.03

0.49

PPARγ2

0.01 ± 0.00

0.01 ± 0.01

0.98

  1. Values are presented as means ± SD. BMI, body mass index (Kg/m2); SBP, systolic blood pressure (mm Hg); DBP, diastolic blood pressure (mm Hg); W-H ratio, waist to hip ratio; Insulin (UI/ml); Glycaemia (mg/dl); HbA1c, glycated haemoglobin (%); HOMA-IR, homeostasis model assessment ((gluc mg/dl*insul U/ml)/405); Cholesterol (mg/dl); TG, triglycerides (mg/dl); LDL-c, low density lipoprotein-cholesterol (mg/dl); HDL-c, high density lipoprotein-cholesterol (mg/dl); CRP, c-reactive protein (mg/l); Adiponectin (ng/ml); Leptin (ng/ml); FASN, fatty acid synthase; PPARγ, peroxisome proliferator-activated receptor. Relationship between variables in control and hyperglycemic individuals was assessed by Student's t test.